| n | CAM treatment use n (%) | Conventional treatment use n (%) | Combined use n (%) | |||
---|---|---|---|---|---|---|---|
 |  | Yes | No | Yes | No | Yes | No |
All participants | 138 | 116 (84) | 22 (16) | 111 (80) | 27 (20) | 95 (69) | 43 (31) |
Age groups | Â | Â | Â | Â | Â | Â | Â |
18–59 | 39 | 37 (95) | 2 (5) | 32 (82) | 7 (18) | 31 (79) | 8 (21) |
60–69 | 51 | 44 (86) | 7 (12) | 42 (82) | 9 (18) | 36 (71) | 15 (29) |
70+ | 48 | 35 (73) | 13 (27) | 37 (77) | 11 (23) | 28 (58) | 20 (42) |
 |  | p = 0.005* | p = 0.544 | p = 0.033 | |||
Gender | Â | Â | Â | Â | Â | Â | Â |
Male | 55 | 43 (78) | 12 (22) | 33 (60) | 22 (40) | 30 (55) | 25 (45) |
Female | 83 | 73 (88) | 10 (12) | 78 (94) | 5 (6) | 65 (78) | 18 (22) |
 |  | p = 0.125 | p < 0.001 | p = 0.003 | |||
Socio-economic class | Â | Â | Â | Â | Â | Â | Â |
Professional or managerial | 68 | 52 (76) | 16 (24) | 50 (74) | 18 (26) | 42 (62) | 26 (38) |
Intermediate | 29 | 29 (100) | 0 (0) | 26 (90) | 3 (10) | 24 (83) | 5 (17) |
Routine or manual | 41 | 35 (85) | 6 (15) | 35 (85) | 6 (15) | 29 (71) | 12 (29) |
 |  | p = 0.014 | p = 0.119 | p = 0.118 | |||
CPG | Â | Â | Â | Â | Â | Â | Â |
I | 37 | 28 (76) | 9 (24) | 25 (68) | 12 (32) | 21 (57) | 16 (43) |
II | 46 | 40 (87) | 6 (13) | 37 (80) | 9 (20) | 32 (70) | 14 (30) |
III | 32 | 29 (91) | 3 (9) | 28 (88) | 4 (12) | 25 (78) | 7 (22) |
IV | 23 | 19 (83) | 4 (17) | 21 (91) | 2 (9) | 16 (70) | 7 (30) |
 |  | p = 0.310 | p = 0.013 | p = 0.156 |